Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Dr. Rath Research Institute is a scientific organization dedicated to the development of "Cellular Medicine," an approach that utilizes micronutrient synergies to address the root causes of chronic diseases. Based in Santa Clara, California, the institute conducts research into cardiovascular health, oncology, and viral infections, with a particular focus on the role of vitamins, amino acids, and minerals in maintaining the integrity of the extracellular matrix. Their research aims to provide natural alternatives to traditional pharmaceutical interventions by demonstrating the efficacy of nutrient-based therapies in preclinical and clinical studies. The institute is led by Dr. Aleksandra Niedzwiecki and was founded by Dr. Matthias Rath, a pioneer in nutritional medicine. Its findings support the product development for the Dr. Rath Health Programs and are disseminated through various scientific publications and public health initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Rath Research Institute.